| Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike L Liu, P Wang, MS Nair, J Yu, M Rapp, Q Wang, Y Luo, JFW Chan, V Sahi, ... Nature 584 (7821), 450-456, 2020 | 1385 | 2020 |
| Antibody evasion by SARS-CoV-2 Omicron subvariants BA. 2.12. 1, BA. 4 and BA. 5 Q Wang, Y Guo, S Iketani, MS Nair, Z Li, H Mohri, M Wang, J Yu, ... Nature 608 (7923), 603-608, 2022 | 657 | 2022 |
| Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants Q Wang, S Iketani, Z Li, L Liu, Y Guo, Y Huang, AD Bowen, M Liu, ... Cell 186 (2), 279-286. e8, 2023 | 535 | 2023 |
| Antibody response to omicron BA. 4–BA. 5 bivalent booster Q Wang, A Bowen, R Valdez, C Gherasim, A Gordon, L Liu, DD Ho New England Journal of Medicine 388 (6), 567-569, 2023 | 168* | 2023 |
| SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease P Wang, L Liu, MS Nair, MT Yin, Y Luo, Q Wang, T Yuan, K Mori, AG Solis, ... Emerging microbes & infections 9 (1), 2091-2093, 2020 | 133 | 2020 |
| Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects HT Nguyen, S Zhang, Q Wang, S Anang, J Wang, H Ding, JC Kappes, ... Journal of Virology 95 (5), 10.1128/jvi. 02304-20, 2021 | 79 | 2021 |
| Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA. 2.75 Q Wang, S Iketani, Z Li, Y Guo, AY Yeh, M Liu, J Yu, Z Sheng, Y Huang, ... Cell host & microbe 30 (11), 1512-1517. e4, 2022 | 75 | 2022 |
| The conformational states of the HIV-1 envelope glycoproteins Q Wang, A Finzi, J Sodroski Trends in microbiology 28 (8), 655-667, 2020 | 74 | 2020 |
| Antigenicity and receptor affinity of SARS-CoV-2 BA. 2.86 spike Q Wang, Y Guo, L Liu, LT Schwanz, Z Li, MS Nair, J Ho, RM Zhang, ... Nature 624 (7992), 639-644, 2023 | 60 | 2023 |
| Resistance of SARS-CoV-2 omicron subvariant BA. 4.6 to antibody neutralisation Q Wang, Z Li, J Ho, Y Guo, AY Yeh, H Mohri, M Liu, M Wang, J Yu, ... The Lancet Infectious Diseases 22 (12), 1666-1668, 2022 | 60 | 2022 |
| Tandem bispecific neutralizing antibody eliminates HIV-1 infection in humanized mice X Wu, J Guo, M Niu, M An, L Liu, H Wang, X Jin, Q Zhang, KS Lam, T Wu, ... The Journal of clinical investigation 128 (6), 2239-2251, 2018 | 55 | 2018 |
| Broadly neutralizing antibodies and vaccine design against HIV-1 infection Q Wang, L Zhang Frontiers of medicine 14 (1), 30-42, 2020 | 34 | 2020 |
| SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster Q Wang, A Bowen, AR Tam, R Valdez, E Stoneman, IA Mellis, A Gordon, ... The Lancet Infectious Diseases 23 (5), 527-528, 2023 | 31 | 2023 |
| XBB. 1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN. 1 Q Wang, Y Guo, A Bowen, IA Mellis, R Valdez, C Gherasim, A Gordon, ... Cell Host & Microbe, 2024 | 30 | 2024 |
| Antibody neutralisation of emerging SARS-CoV-2 subvariants: EG. 5.1 and XBC. 1.6 Q Wang, Y Guo, RM Zhang, J Ho, H Mohri, R Valdez, DM Manthei, ... The Lancet Infectious Diseases 23 (10), e397-e398, 2023 | 27 | 2023 |
| Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B. 1.1. 529 Q Wang, S Anang, S Iketani, Y Guo, L Liu, PS Katsamba, L Shapiro, ... Cell Reports 39 (11), 2022 | 27 | 2022 |
| Deep immunological imprinting due to the ancestral spike in the current bivalent COVID-19 vaccine Q Wang, Y Guo, AR Tam, R Valdez, A Gordon, L Liu, DD Ho Cell Reports Medicine 4 (11), 2023 | 23 | 2023 |
| Functional differences among the spike glycoproteins of multiple emerging severe acute respiratory syndrome coronavirus 2 variants of concern Q Wang, MS Nair, S Anang, S Zhang, H Nguyen, Y Huang, L Liu, DD Ho, ... Iscience 24 (11), 2021 | 15 | 2021 |
| Antibodies targeting a quaternary site on SARS-CoV-2 spike glycoprotein prevent viral receptor engagement by conformational locking L Liu, RG Casner, Y Guo, Q Wang, S Iketani, JFW Chan, J Yu, ... Immunity 56 (10), 2442-2455. e8, 2023 | 13* | 2023 |
| Stabilized diverse HIV-1 envelope trimers for vaccine design Q Wang, B Ma, Q Liang, A Zhu, H Wang, L Fu, X Han, X Shi, Y Xiang, ... Emerging microbes & infections 9 (1), 775-786, 2020 | 13 | 2020 |
Lihong LiuColumbia UinversityПотвърден имейл адрес: cumc.columbia.edu
